Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Total Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Total Liabilities for 5 consecutive years, with $2.4 million as the latest value for Q3 2020.

  • Quarterly Total Liabilities fell 95.27% to $2.4 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Sep 2020, down 95.27% year-over-year, with the annual reading at $17.3 million for FY2019, 61.47% down from the prior year.
  • Total Liabilities for Q3 2020 was $2.4 million at Forte Biosciences, down from $3.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $50.9 million in Q3 2019, with the low at $2.4 million in Q3 2020.
  • Average Total Liabilities over 5 years is $29.2 million, with a median of $25.3 million recorded in 2016.
  • The sharpest move saw Total Liabilities skyrocketed 161.65% in 2019, then plummeted 95.27% in 2020.
  • Over 5 years, Total Liabilities stood at $28.4 million in 2016, then fell by 25.97% to $21.0 million in 2017, then surged by 114.07% to $44.9 million in 2018, then crashed by 61.47% to $17.3 million in 2019, then crashed by 86.07% to $2.4 million in 2020.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $2.4 million, $3.4 million, and $16.6 million for Q3 2020, Q2 2020, and Q1 2020 respectively.